硼替佐米引起的周围神经病变与多发性骨髓瘤患者外周血中脑源性神经营养因子水平的改变有关。 - Suppr

Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma.

作者信息

Azoulay David, Lavie David, Horowitz Netanel, Suriu Celia, Gatt Moshe E, Akria Luiza, Perlman Riki, Braester Andrei, Ben-Yehuda Dina

机构信息

Haematology Institute, Western Galilee Hospital, Naharia, Israel; Bar Ilan Faculty of Medicine, Safed, Israel.

出版信息

Br J Haematol. 2014 Feb;164(3):454-6. doi: 10.1111/bjh.12624. Epub 2013 Oct 25.

DOI:10.1111/bjh.12624

PMID:24164472

Abstract

摘要

相似文献

Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma.

Br J Haematol. 2014 Feb;164(3):454-6. doi: 10.1111/bjh.12624. Epub 2013 Oct 25.

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.

Lancet Oncol. 2010 Nov;11(11):1057-65. doi: 10.1016/S1470-2045(10)70206-0. Epub 2010 Sep 21.

General aspects and mechanisms of peripheral neuropathy associated with bortezomib in patients with newly diagnosed multiple myeloma.

Semin Hematol. 2012 Jul;49(3):249-57. doi: 10.1053/j.seminhematol.2012.04.001.

Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients.

Leuk Res. 2010 Apr;34(4):471-4. doi: 10.1016/j.leukres.2009.07.022. Epub 2009 Aug 11.

Bortezomib-induced inflammatory neuropathy.

J Peripher Nerv Syst. 2010 Dec;15(4):366-8. doi: 10.1111/j.1529-8027.2010.00287.x.

Bortezomib: the subtle line between drug-induced peripheral neuropathy and post-herpetic neuralgia.

Clin Lymphoma Myeloma. 2009 Aug;9(4):E16-7. doi: 10.3816/CLM.2009.n.067.

An acceptable incidence of infusion site reactions after subcutaneous bortezomib administration in the upper arm in Japanese patients with multiple myeloma.

Acta Haematol. 2015;133(1):29-30. doi: 10.1159/000362587. Epub 2014 Jul 1.

Subcutaneous bortezomib: a step towards optimised drug use.

Lancet Oncol. 2011 May;12(5):410-1. doi: 10.1016/S1470-2045(11)70098-5. Epub 2011 Apr 18.

Bortezomib-induced peripheral neuropathy in patients with multiple myeloma.

Clin J Oncol Nurs. 2012 Feb;16(1):86-9. doi: 10.1188/12.CJON.86-89.

Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.

J Clin Oncol. 2006 Jul 1;24(19):3113-20. doi: 10.1200/JCO.2005.04.7779. Epub 2006 Jun 5.

引用本文的文献

Mechanisms and treatment of cancer therapy-induced peripheral and central neurotoxicity.

Nat Rev Cancer. 2025 Sep 9. doi: 10.1038/s41568-025-00863-2.

Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers.

Front Oncol. 2022 Aug 17;12:942960. doi: 10.3389/fonc.2022.942960. eCollection 2022.

Blood biomarkers of peripheral neuropathy.

Acta Neurol Scand. 2022 Oct;146(4):325-331. doi: 10.1111/ane.13650. Epub 2022 May 25.

Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions.

Front Pain Res (Lausanne). 2022 Mar 14;3:864910. doi: 10.3389/fpain.2022.864910. eCollection 2022.

Fluid Biomarkers for Monitoring Structural Changes in Polyneuropathies: Their Use in Clinical Practice and Trials.

Neurotherapeutics. 2021 Oct;18(4):2351-2367. doi: 10.1007/s13311-021-01136-0. Epub 2021 Oct 18.

Prediction of Chemotherapy-Induced Peripheral Neuropathy in Patients with Lymphoma and Myeloma: the Roles of Brain-Derived Neurotropic Factor Protein Levels and A Gene Polymorphism.

J Clin Neurol. 2019 Oct;15(4):511-516. doi: 10.3988/jcn.2019.15.4.511.

Axonal Transport Impairment in Chemotherapy-Induced Peripheral Neuropathy.

Toxics. 2015 Aug 7;3(3):322-341. doi: 10.3390/toxics3030322.

Impact of dose modification on intravenous bortezomib-induced peripheral neuropathy in multiple myeloma patients.

Support Care Cancer. 2014 Oct;22(10):2669-75. doi: 10.1007/s00520-014-2256-6. Epub 2014 Apr 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma.

作者信息

Azoulay David, Lavie David, Horowitz Netanel, Suriu Celia, Gatt Moshe E, Akria Luiza, Perlman Riki, Braester Andrei, Ben-Yehuda Dina

机构信息

Haematology Institute, Western Galilee Hospital, Naharia, Israel; Bar Ilan Faculty of Medicine, Safed, Israel.

出版信息

Br J Haematol. 2014 Feb;164(3):454-6. doi: 10.1111/bjh.12624. Epub 2013 Oct 25.

DOI:10.1111/bjh.12624

PMID:24164472

Abstract

摘要

相似文献

Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma.

Br J Haematol. 2014 Feb;164(3):454-6. doi: 10.1111/bjh.12624. Epub 2013 Oct 25.

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.

Lancet Oncol. 2010 Nov;11(11):1057-65. doi: 10.1016/S1470-2045(10)70206-0. Epub 2010 Sep 21.

General aspects and mechanisms of peripheral neuropathy associated with bortezomib in patients with newly diagnosed multiple myeloma.

Semin Hematol. 2012 Jul;49(3):249-57. doi: 10.1053/j.seminhematol.2012.04.001.

Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients.

Leuk Res. 2010 Apr;34(4):471-4. doi: 10.1016/j.leukres.2009.07.022. Epub 2009 Aug 11.

Bortezomib-induced inflammatory neuropathy.

J Peripher Nerv Syst. 2010 Dec;15(4):366-8. doi: 10.1111/j.1529-8027.2010.00287.x.

Bortezomib: the subtle line between drug-induced peripheral neuropathy and post-herpetic neuralgia.

Clin Lymphoma Myeloma. 2009 Aug;9(4):E16-7. doi: 10.3816/CLM.2009.n.067.

An acceptable incidence of infusion site reactions after subcutaneous bortezomib administration in the upper arm in Japanese patients with multiple myeloma.

Acta Haematol. 2015;133(1):29-30. doi: 10.1159/000362587. Epub 2014 Jul 1.

Subcutaneous bortezomib: a step towards optimised drug use.

Lancet Oncol. 2011 May;12(5):410-1. doi: 10.1016/S1470-2045(11)70098-5. Epub 2011 Apr 18.

Bortezomib-induced peripheral neuropathy in patients with multiple myeloma.

Clin J Oncol Nurs. 2012 Feb;16(1):86-9. doi: 10.1188/12.CJON.86-89.

Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.

J Clin Oncol. 2006 Jul 1;24(19):3113-20. doi: 10.1200/JCO.2005.04.7779. Epub 2006 Jun 5.

引用本文的文献

Mechanisms and treatment of cancer therapy-induced peripheral and central neurotoxicity.

Nat Rev Cancer. 2025 Sep 9. doi: 10.1038/s41568-025-00863-2.

Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers.

Front Oncol. 2022 Aug 17;12:942960. doi: 10.3389/fonc.2022.942960. eCollection 2022.

Blood biomarkers of peripheral neuropathy.

Acta Neurol Scand. 2022 Oct;146(4):325-331. doi: 10.1111/ane.13650. Epub 2022 May 25.

Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions.

Front Pain Res (Lausanne). 2022 Mar 14;3:864910. doi: 10.3389/fpain.2022.864910. eCollection 2022.

Fluid Biomarkers for Monitoring Structural Changes in Polyneuropathies: Their Use in Clinical Practice and Trials.

Neurotherapeutics. 2021 Oct;18(4):2351-2367. doi: 10.1007/s13311-021-01136-0. Epub 2021 Oct 18.

Prediction of Chemotherapy-Induced Peripheral Neuropathy in Patients with Lymphoma and Myeloma: the Roles of Brain-Derived Neurotropic Factor Protein Levels and A Gene Polymorphism.

J Clin Neurol. 2019 Oct;15(4):511-516. doi: 10.3988/jcn.2019.15.4.511.

Axonal Transport Impairment in Chemotherapy-Induced Peripheral Neuropathy.

Toxics. 2015 Aug 7;3(3):322-341. doi: 10.3390/toxics3030322.

Impact of dose modification on intravenous bortezomib-induced peripheral neuropathy in multiple myeloma patients.

Support Care Cancer. 2014 Oct;22(10):2669-75. doi: 10.1007/s00520-014-2256-6. Epub 2014 Apr 26.

Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献